Eli Lilly and Company
An Eli Lilly and Company scientist joined the lab and four other companies on electrocatalytic decarboxylative cross-coupling for complex molecule synthesis.
Indianapolis, Indiana
- Papers together
- 1
- Years
- 2023
- Co-authors
- 1
The record
Our paper with Lilly
-
Complex Molecule Synthesis by Electrocatalytic Decarboxylative Cross-Coupling
- Bristol Myers Squibb Martins S. Oderinde, Maximilian D. Palkowitz, Michael D. Mandler, T. G. Murali Dhar
- Pfizer Daniel C. Schmitt, Michael R. Collins
- LEO Pharma Nadia Nasser Petersen, Sebastian Clementson
- Biogen Philippe N. Bolduc, TeYu Chen
- Lilly Daniel C. Schmitt
No papers match these filters.
Our co-authors at Lilly
Daniel C. Schmitt
Some of these papers were shared with 4 other partners: Bristol Myers Squibb, Pfizer, LEO Pharma, Biogen.
Keep exploring
More partners
Enamine
HitGen Hongene Biotech Hongene Biotech IKA IKA InduPro Therapeutics InduPro Therapeutics
KULR Technology RQx Pharmaceuticals RQx Pharmaceuticals Socrates Biosciences Socrates Biosciences The Medicines Company The Medicines Company Work with us
Interested in collaborating with the Baran lab?
If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.
Email Philor write to pbaran@scripps.edu